Method and device of artificial endocrine pancreas
Abstract
Abstract A method for treating and changing the constitution of blood or other body fluid as the pancreatic islet cells effects such change normally in the blood or other body fluid passing therethrough in a live animal, in cooperation with or substitution for the animal endocrine pancreas; and a device for carrying out such treatment. The method comprises positioning on one side of a semi-permeable membrane and in contact therewith body fluid to be treated and the positioning on the opposite side of the membrane and proximate therewith once dispersed live pancreatic islet cells. The device comprises means associated with the membrane for positioning body fluid in contact with one side of the membrane, conduit means for introducing such fluid to and withdrawing it from the membrane, and once dispersed live pancreatic islet cells disposed on the other side of the membrane out of direct contact with the fluid. Additionally, the device may have a second membrane for dialyzing the fluid.
Inventors
- 👤 K Matsumura
Bibliographic Details
Claims Analysis
Total Claims: 11References Cited (Backward Citations)
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1977-08-05 | 1978-02-04 | 1978-08-06 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1981-08-05 | 1982-02-04 | 1982-08-06 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 1985-08-05 | 1986-02-04 | 1986-08-06 | $7700.00 | Window Closed / Lapsed |